EUROFINS TESTING FOR A BETTER WORLD
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

EUROFINS TESTING FOR A BETTER WORLD Trademark

Serial Number: 79218147 • Registration: 5588463

EUROFINS TESTING FOR A BETTER WORLD is a trademark filed by EUROFINS SCIENTIFIC (IRELAND) LIMITED on May 16, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

EUROFINS SCIENTIFIC (IRELAND) LIMITED (44 trademarks)

Entity Type: 99

Trademark Details

Filing Date

May 16, 2017

Registration Date

October 23, 2018

Published for Opposition

August 7, 2018

Cancellation Date

May 9, 2025

Goods & Services

Research and development in the fields of animal and plant biology, physico-chemical and microbiology; research services, namely, performing physical, chemical, physico-chemical, biochemical, biological and microbiological analyzes in the fields of plant and animal products; research services, namely, carrying out physical, chemical, physico-chemical, biochemical, biological or microbiological analyzes in the food, chemical, pharmaceutical, cosmetic and environmental industries; research services, namely, performing genetic analyzes in the fields of plant and animal products; research services, namely, carrying out genetic analyzes in the food, chemical, pharmaceutical, cosmetic and environmental industries; research services, namely, nuclear magnetic resonance analyzes in the food, chemical, pharmaceutical, cosmetic and environmental industries; development of new technology for others, namely, method development services, namely, establishing and maintaining chemical, biological, biomolecular test methods; conducting scientific projects feasibility studies; professional consulting in the field of scientific research

Apparatus for diagnosis, measurement and analysis, not for medical use, namely, spectroscopy instruments, namely, readers for ELISA, namely, microplate readers, test strip readers and tube readers; laboratory equipment, namely, photometers; software for the establishment, systematization, evaluation and/or collection of analytical and diagnostics data

Personnel placement services, namely, provision of specialized personnel for scientific analysis in the fields of research and development, in the fields of chemical analysis, physico-chemical, biochemistry, molecular biology, virology, and cell biology

Diagnostic preparations for medical and veterinary use; chemical analysis reagents for medical and veterinary use; biological reagents for medical and veterinary use; diagnostic reagents for medical and veterinary use; chemical reagents for medical and veterinary use; oligonucleotides for medical and veterinary use; poly-nucleotides, and synthetic genes for medical and veterinary use; genetic engineering chemicals, namely, genes, gene fragments and combinations thereof for medical purposes

Chemical preparations for scientific purposes not for medical use; diagnostic preparations for scientific use; molecular tools, namely, reagents such as probes, reaction primers and test fractions for analysis and diagnosis, all for scientific use; molecular preparations, namely, biochemical reagents, namely, probes, reaction primers and test fractions for analysis and diagnosis, all for scientific use; analytical and diagnostic testing preparations for scientific and research use, including reagents and buffers; chemical compounds for scientific use and in the field of research, and not for medical use, in particular oligonucleotides, poly-nucleotides, synthetic genes; oligonucleotide sequences for DNA micro-arrays for scientific purposes; genetic engineering chemicals, namely, genes, gene fragments and combinations thereof for scientific purposes

Medical services, namely, blood testing, saliva testing and body fluid testing; medical services, namely, serological and urinary testing services; medical testing services in the field of genetics, namely, birth defects and prenatal testing; DNA screening for medical purposes; medical and health services related to DNA, namely, genetic testing for medical uses; hospital services; medical services and medical services in the field of genetics; medical clinic services; medical consultancy services; genetic counseling; medical equipment rental; maintaining personal medical history records and files online; human fertility treatment services; hygiene and beauty care for human beings and animals; collection and preservation of human blood; medical testing for diagnostic purposes; information relating to cardiovascular health and cardiovascular health analysis; medical services, namely, a program to improve health and quality of life in the field of cardiovascular diseases, namely, medical monitoring and reporting in the field of cardiovascular diseases; medical diagnostic tests in the field of diabetes

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Aug 15, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 15, 2026 XXCR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 23, 2026 NREP
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 9, 2026 INTR
CANCELLED SECTION 71
May 9, 2025 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2019 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 5, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 5, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 23, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 23, 2018 R.PR
PUBLISHED FOR OPPOSITION
Aug 7, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Aug 4, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 18, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 18, 2018 OP2R
NOTICE OF PUBLICATION
Jul 18, 2018 NPUB
EXAMINERS AMENDMENT MAILED
Jul 5, 2018 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 3, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 3, 2018 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 3, 2018 CNEA
FINAL REFUSAL MAILED
Jun 21, 2018 CNFR
FINAL REFUSAL WRITTEN
Jun 20, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2018 CRFA
ASSIGNED TO LIE
May 11, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 7, 2018 TROA
ASSIGNED TO EXAMINER
Apr 25, 2018 DOCK
REFUSAL PROCESSED BY IB
Nov 24, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 6, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 6, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 31, 2017 RFCR
NON-FINAL ACTION WRITTEN
Oct 30, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 20, 2017 MAFR
ASSIGNED TO EXAMINER
Oct 16, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 12, 2017 REPR